Management

Calando Scientific Advisory Board

John J. Rossi, Ph.D.
Dr. Rossi is widely regarded as a world leader in the development of RNA interference and in clinical research with nucleic acids for the treatment of various diseases. He currently serves as an Associate Director of Laboratory Research at the City of Hope Comprehensive Cancer Center. Dr. Rossi is the Lidow family Professor and Chair of the Division of Molecular Biology, Beckman Research Institute of the City of Hope. Since 1998, Dr. Rossi served as Dean of the City of Hope Graduate School of Biological Sciences. He is also an Adjunct Professor, Division of Biomedical Sciences, University of California, Riverside, CA, as well as an Adjunct Professor, Department of Biochemistry and Microbiology, Loma Linda University, CA. He Co-Founded Dicerna Pharmaceuticals, Inc. and has been its Chairman and Member of Scientific Advisory Board since October 2008. He served as Chairman of Scientific Advisory Board of Benitec Ltd. and serves as its Member of Scientific Advisory Board. He has been Member of the Scientific Advisory Board of Kylin Therapeutics, Inc. since July 1, 2010. He serves as a Member of the Scientific Advisory Board for VIRxSYS Corporation. He has been a Member of Scientific Advisory Board of Nanoviricides, Inc. since July 14, 2005. He served as a Director of Cytogenix Inc. from November 11, 2003 to November 19, 2010. In 2002 he received the Merit Award from the Division of AIDS of the National Institute of Allergy and Infectious Diseases. In 1993, City of Hope bestowed its highest honor upon him by naming him to its Gallery of Medical and Scientific Achievement for his pioneering work at the molecular level in the battle against AIDS and other major diseases. He has authored more than 275 peer-reviewed papers and more than 70 book chapters.

Timothy J. Triche, M.D., Ph.D.
Dr. Triche is a Professor of Pathology and Pediatrics at the University of Southern California ("USC") Keck School of Medicine where he manages a large cancer genomics, biology, and nanotechnology laboratory research program at USC. He served as Pathologist in Chief at Children's Hospital Los Angeles (CHLA) from 1988 until 2010, and now directs a program in pediatric personalized medicine at CHLA. Dr. Triche received his undergraduate degree in physics and biology from Cornell University, his M.D. and Ph.D. degrees from Tulane University, and did his residency training at Washington University School of Medicine, followed by a fellowship at the National Cancer Institute in Bethesda, MD, prior to becoming a tenured faculty member there for 14 years.